Table 2.
Treatments | Days of storage at room temperature (25°C) | Days of storage at cold temperature (12°C) | |||||||
---|---|---|---|---|---|---|---|---|---|
1 | 4 | 8 | 12 | 1 | 6 | 12 | 18 | 24 | |
WEIGTH LOSS (%) | |||||||||
Control | 0.00 (±0.00)D | 1.99 (±0.01)aC | 6.22 (±0.01)aB | 10.85 (±0.02)aA | 0.00 (±0.00)E | 0.52 (±0.06)aD | 2.39 (±0.06)aC | 4.49 (±0.08)aB | 6.21 (±0.03)aA |
CHI 4 | 0.00 (±0.00)D | 1.75 (±0.02)bC | 6.01 (±0.04)bB | 8.01 (±0.03)cA | 0.00 (±0.00)E | 0.36 (±0.06)bD | 1.32 (±0.04)bC | 2.23 (±0.07)bB | 4.19 (±0.02)bA |
OVEO 1.25 | 0.00 (±0.00)D | 1.94 (±0.01)aC | 6.11 (±0.02)abB | 9.82 (±0.02)bA | 0.00 (±0.00)E | 0.49 (±0.04)aD | 1.54 (±0.05)bC | 2.44 (±0.03)bB | 4.81 (±0.01)bA |
CHI4 + OVEO 1.25 | 0.00 (±0.00)D | 1.20 (±0.01)cC | 4.37 (±0.03)cB | 6.58 (±0.01)dA | 0.00 (±0.00)E | 0.30 (±0.03)bD | 1.02 (±0.05)cC | 1.74 (±0.02)cB | 3.80 (±0.02)cA |
FIRMNESS (N/mm) | |||||||||
Control | 10.55 (±0.05)bA | 8.63 (±0.03)bB | 7.94 (±0.07)bC | 6.40 (±0.04)cD | 10.15 (±0.07)bcA | 10.01 (±0.04)aA | 9.23 (±0.04)bB | 8.51 (±0.03)bC | 6.31 (±0.03)cD |
CHI 4 | 8.94 (±0.05)dA | 7.54 (±0.03)cB | 7.47 (±0.01)cB | 7.19 (±0.02)bC | 10.09 (±0.04)cA | 8.98 (±0.02)bB | 8.61 (±0.03)cC | 8.06 (±0.04)cD | 7.54 (±0.03)bD |
OVEO 1.25 | 9.65 (±0.02)cA | 8.44 (±0.08)bB | 7.30 (±0.04)cB | 6.54 (±0.03)cB | 10.33 (±0.03)bA | 8.75 (±0.04)bB | 8.34 (±0.03)cB | 7.34 (±0.04)dC | 6.40 (±0.04)cD |
CHI4 + OVEO 1.25 | 11.36 (±0.03)aA | 9.26 (±0.02)aB | 8.17 (±0.05)aC | 8.07 (±0.02)aC | 12.68 (±0.04)aA | 10.22 (±0.05)aB | 9.94 (±0.02)aC | 9.15 (±0.05)aD | 8.77 (±0.01)aE |
TITRABLE ACIDITY (mg/100 g OF CITRIC ACID) | |||||||||
Control | 12.39 (±0.05)aA | 10.26 (±0.06)aB | 9.40 (±0.03)aBC | 8.43 (±0.03)cC | 11.71 (±0.08)aA | 10.59 (±0.07)bB | 9.05 (±0.21)bC | 8.51 (±0.05)bD | 8.11 (±0.03)cE |
CHI 4 | 9.87 (±0.09)cA | 9.56 (±0.15)aA | 9.50 (±0.06)aA | 9.33 (±0.04)bA | 11.10 (±0.01)BA | 11.04 (±0.07)aA | 11.02 (±0.09)aA | 10.99 (±0.01)aA | 10.97 (±0.01)aA |
OVEO 1.25 | 9.67 (±0.01)cA | 9.47 (±0.06)aA | 9.37 (±0.02)aA | 9.11 (±0.09)bcA | 11.09 (±0.05)bA | 10.99 (±0.01)aB | 10.95 (±0.05)aB | 10.93 (±0.02)aB | 10.92 (±0.03)bB |
CHI 4 + OVEO 1.25 | 10.86 (±0.14)bA | 10.44 (±0.18)aA | 10.37 (±0.06)aA | 10.34 (±0.05)aA | 11.06(±0.04)bA | 11.09 (±0.01)aB | 10.98 (±0.01)aB | 10.97 (±0.02)aB | 10.95 (±0.01)abB |
TOTAL SOLUBLE SOLIDS (°BRIX) | |||||||||
Control | 7.15 (±0.07)aA | 6.85 (±0.08)bAB | 6.60 (±0.01)cB | 6.10 (±0.14)bC | 6.70 (±0.02)aA | 6.35 (±0.05)aB | 6.05 (±0.07)aB | 5.70 (±0.00)aC | 5.40 (±0.09)bC |
CHI 4 | 7.10 (±0.14)aA | 7.05 (±0.06)abA | 6.90 (±0.02)bA | 6.85 (±0.07)aA | 6.05 (±0.01)bA | 6.00 (±0.03)bA | 5.96 (±0.03)aA | 5.90 (±0.04)aA | 5.85 (±0.07)aA |
OVEO 1.25 | 7.08 (±0.14)aA | 7.00 (±0.07)abA | 6.95 (±0.07)abA | 6.90 (±0.01)aA | 6.00 (±0.01)bA | 5.97 (±0.07)bA | 5.95 (±0.02)aA | 5.93 (±0.07)aA | 5.75 (±0.06)abA |
CHI 4 + OVEO 1.25 | 7.20 (±0.00)aA | 7.15 (±0.05)aA | 7.08 (±0.04)aA | 7.05 (±0.07)aA | 6.05 (±0.07)bA | 5.98 (±0.04)bA | 5.92 (±0.03)bA | 5.90 (±0.02)aA | 5.85 (±0.04)aA |
Lycopene (μg/g)* | 1–12 days | 1–24 days | |||||||
Control | CHI 4 | OVEO 1.25 | CHI 4 + OV 1.25 | Control | CHI 4 | OVEO 1.25 | CHI 4 + OV 1.25 | ||
−8.80 (±0.02)a | −6.25 (±0.01)b | −6.24 (±0.03)b | −4.21 (±0.02)c | −7.77 (±0.04)a | −5.10 (±0.01)c | −5.64 (±0.02)b | −3.49 (±0.02)d |
Control: 0 μL/mL of chitosan and essential oil; CHI 4 + OVEO 1.25: CHI 4 mg/mL + OVEO 1.25 μL/mL. A–E: For each trial, different superscript letters in the same row denote differences (p ≤ 0.05) among the mean values (for the same treatment at different storage periods) according to Tukey's test. a–d: For each trial, different superscript letters in the same column denote differences (p ≤ 0.05) among the mean values (for the different treatments at a same storage period) according to Tukey's test.
Mean ± standard deviations of (+) increase or decrease (−) amounts during the storage period.